Kumpulan Info tentang,
UNIVERSITAS SURABAYA
| No | Source Title | CiteScore | Quartile | Publisher | Highest percentile | Citations 2021-24 | Documents 2021-24 |
|---|---|---|---|---|---|---|---|
| 28741 | Expert Review of Vaccines | 11.2 | Q1 | Taylor & Francis | 91.0% 29/321 Pharmacology | 5031 | 450 |
| 28742 | Journal of Enzyme Inhibition and Medicinal Chemistry | 11.2 | Q1 | Taylor & Francis | 91.0% 28/321 Pharmacology | 7616 | 679 |
| 28743 | Vaccines | 9.9 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 91.0% 24/275 Pharmacology (medical) | 67553 | 6840 |
| 28744 | MedComm | 8.8 | Q1 | John Wiley & Sons | 88.0% 12/100 Genetics (clinical) | 5743 | 654 |
| 28745 | Molecules | 8.6 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 87.0% 26/212 Organic Chemistry | 263651 | 30708 |
| 28746 | Drug Design, Development and Therapy | 8.6 | Q1 | Dove Medical Press | 84.0% 51/321 Pharmacology | 11459 | 1329 |
| 28747 | npj Systems Biology and Applications | 4.4 | Q1 | Springer Nature | 81.0% 122/665 Applied Mathematics | 1349 | 306 |
| 28748 | PPAR Research | 7 | Q1 | John Wiley & Sons | 80.0% 54/275 Pharmacology (medical) | 400 | 57 |
| 28749 | Pharmaceuticals | 7.7 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 79.0% 39/185 Pharmaceutical Science | 48523 | 6311 |
| 28750 | Journal of Pharmacy and Pharmacognosy Research | 3.2 | Q1 | Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) | 75.0% 12/47 Pharmacy | 1171 | 371 |
| 28751 | ACS Bio and Med Chem Au | 6.6 | Q2 | American Chemical Society | 74.0% 48/185 Pharmaceutical Science | 873 | 132 |
| 28752 | Journal of Ayurveda and Integrative Medicine | 4 | Q2 | Elsevier | 70.0% 34/112 Complementary and Alternative Medicine | 1987 | 500 |
| 28753 | Therapeutic Advances in Vaccines and Immunotherapy | 5 | Q2 | SAGE | 63.0% 100/275 Pharmacology (medical) | 312 | 62 |
| 28754 | Cancer Innovation | 2 | Q2 | John Wiley & Sons | 61.0% 18/46 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 230 | 115 |
| 28755 | Natural Product Communications | 2.6 | Q2 | SAGE | 60.0% 45/112 Complementary and Alternative Medicine | 2631 | 1011 |
| 28756 | Human Genomics | 5.4 | Q3 | Springer Nature | 59.0% 143/348 Genetics | 2027 | 378 |
| 28757 | Emerging Trends in Drugs, Addictions, and Health | 3 | Q3 | Elsevier | 58.0% 181/433 Medicine (miscellaneous) | 222 | 75 |
| 28758 | Antibodies | 4.5 | Q3 | Multidisciplinary Digital Publishing Institute (MDPI) | 49.0% 80/156 Drug Discovery | 1389 | 306 |
| 28759 | Drug Development and Registration | 1.2 | Q3 | Center of Pharmaceutical Analytics | 45.0% 26/47 Pharmacy | 484 | 410 |
| 28760 | Frontiers in Antibiotics | 2 | Q3 | Frontiers Media S.A. | 32.0% 240/357 Infectious Diseases | 124 | 62 |
| 28761 | Ukrains'kij Zurnal Vijskovoi Medicini | 0.6 | Q3 | Ukrainian Military Medical Academy | 24.0% 329/433 Medicine (miscellaneous) | 160 | 257 |
| 28762 | Journal of HerbMed Pharmacology | 2.4 | Q3 | Shahrekord University of Medical Sciences | 24.0% 118/156 Drug Discovery | 600 | 253 |
| 28763 | Journal of Integrative Environmental Sciences | 5.9 | Q1 | Taylor & Francis | 80.0% 132/687 Public Health, Environmental and Occupational Health | 259 | 44 |
| 28764 | Green Carbon | 8 | Q1 | KeAi Communications Co. | 79.0% 91/441 Biochemistry | 440 | 55 |
| 28765 | International Journal of Industrial Engineering and Operations Management | 4.3 | Q1 | Emerald Publishing | 79.0% 37/175 Statistics, Probability and Uncertainty | 139 | 32 |
| 28766 | Renewable and Sustainable Energy Transition | 10.6 | Q1 | Elsevier | 79.0% 21/100 Energy (miscellaneous) | 819 | 77 |
| 28767 | Green Processing and Synthesis | 6.1 | Q1 | Walter de Gruyter | 77.0% 92/402 Industrial and Manufacturing Engineering | 2543 | 416 |
| 28768 | Biomass (Switzerland) | 4.2 | Q1 | Multidisciplinary Digital Publishing Institute (MDPI) | 77.0% 40/175 Forestry | 532 | 126 |
| 28769 | Global Energy Interconnection | 6 | Q1 | KeAi Communications Co. | 77.0% 31/133 Automotive Engineering | 1453 | 243 |
| 28770 | Wind Energy Science | 7.5 | Q1 | Copernicus Publications | 76.0% 70/299 Energy Engineering and Power Technology | 3202 | 429 |